These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 20003582)

  • 21. Executive impairment in Parkinson's disease: response automaticity and task switching.
    Cameron IG; Watanabe M; Pari G; Munoz DP
    Neuropsychologia; 2010 Jun; 48(7):1948-57. PubMed ID: 20303998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Verbal and visuospatial memory in lateral onset Parkinson disease: time is of the essence.
    Foster PS; Drago V; Crucian GP; Skidmore F; Rhodes RD; Shenal BV; Skoblar B; Heilman KM
    Cogn Behav Neurol; 2010 Mar; 23(1):19-25. PubMed ID: 20299859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive predictors of dementia in Parkinson's disease: a community-based, 4-year longitudinal study.
    Janvin CC; Aarsland D; Larsen JP
    J Geriatr Psychiatry Neurol; 2005 Sep; 18(3):149-54. PubMed ID: 16100104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument.
    Kalbe E; Calabrese P; Kohn N; Hilker R; Riedel O; Wittchen HU; Dodel R; Otto J; Ebersbach G; Kessler J
    Parkinsonism Relat Disord; 2008; 14(2):93-101. PubMed ID: 17707678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A brief neuropsychological protocol for assessing patients with Parkinson's disease.
    Ong JC; Seel RT; Carne WF; Brown R; Pegg PO; Jehle PJ
    NeuroRehabilitation; 2005; 20(3):191-203. PubMed ID: 16340100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Executive functioning in unipolar depression: a review].
    Fossati P; Ergis AM; Allilaire JF
    Encephale; 2002; 28(2):97-107. PubMed ID: 11972136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Parkinson disease and cognition].
    Kulisevsky J; Pascual-Sedano B
    Neurologia; 1999 May; 14 Suppl 1():72-81. PubMed ID: 10377731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired perception of vocal emotions in Parkinson's disease: influence of speech time processing and executive functioning.
    Breitenstein C; Van Lancker D; Daum I; Waters CH
    Brain Cogn; 2001 Mar; 45(2):277-314. PubMed ID: 11237372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive dysfunctions in mild Parkinson's disease dementia: comparison with patients having mild Alzheimer's disease and normal controls.
    Song IU; Kim JS; Yoo JY; Song HJ; Lee KS
    Eur Neurol; 2008; 59(1-2):49-54. PubMed ID: 17917458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Executive dysfunction in non-demented Parkinson's disease patients with hallucinations.
    Imamura K; Wada-Isoe K; Kitayama M; Nakashima K
    Acta Neurol Scand; 2008 Apr; 117(4):255-9. PubMed ID: 17922890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Executive function deficits in children with fetal alcohol spectrum disorders (FASD) measured using the Cambridge Neuropsychological Tests Automated Battery (CANTAB).
    Green CR; Mihic AM; Nikkel SM; Stade BC; Rasmussen C; Munoz DP; Reynolds JN
    J Child Psychol Psychiatry; 2009 Jun; 50(6):688-97. PubMed ID: 19175817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The independent influence of apathy and depression on cognitive functioning in Parkinson's disease.
    Butterfield LC; Cimino CR; Oelke LE; Hauser RA; Sanchez-Ramos J
    Neuropsychology; 2010 Nov; 24(6):721-30. PubMed ID: 20853956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and neuropsychological correlates of impaired awareness of deficits in Alzheimer disease and Parkinson disease: a comparative study.
    Seltzer B; Vasterling JJ; Mathias CW; Brennan A
    Neuropsychiatry Neuropsychol Behav Neurol; 2001; 14(2):122-9. PubMed ID: 11417666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frontal assessment battery in patients with Parkinson disease in a Turkish population.
    Kenangil G; Orken DN; Ur E; Forta H
    Cogn Behav Neurol; 2010 Mar; 23(1):26-8. PubMed ID: 20299860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia.
    Vendette M; Gagnon JF; Décary A; Massicotte-Marquez J; Postuma RB; Doyon J; Panisset M; Montplaisir J
    Neurology; 2007 Nov; 69(19):1843-9. PubMed ID: 17984452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristic of cognitive decline in Parkinson's disease: a 1-year follow-up.
    McKinlay A; Grace RC
    Appl Neuropsychol; 2011 Oct; 18(4):269-77. PubMed ID: 22074065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive impairment and dementia in Parkinson's disease.
    Pagonabarraga J; Kulisevsky J
    Neurobiol Dis; 2012 Jun; 46(3):590-6. PubMed ID: 22484304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A holistic analysis of relationships between executive function and memory in Parkinson's disease.
    Alonso Recio L; Martín P; Carvajal F; Ruiz M; Serrano JM
    J Clin Exp Neuropsychol; 2013; 35(2):147-59. PubMed ID: 23289666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Olfactory deficits and cognitive dysfunction in Parkinson's disease.
    Parrao T; Chana P; Venegas P; Behrens MI; Aylwin ML
    Neurodegener Dis; 2012; 10(1-4):179-82. PubMed ID: 22343138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.